Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Filings indexed 1,297 across all filing types
Latest filing 2014-02-06 Regulatory Filings
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Response to ASX price query 3 pages 159.8KB
Regulatory Filings Classification · 100% confidence The document is a letter from ASX Compliance to Phylogica Limited regarding a price and volume query about the company's securities. It includes questions about whether the company is aware of any undisclosed information that could explain recent trading activity, compliance with listing rules, and potential trading halts. The content is a regulatory inquiry and response related to market disclosure obligations under ASX Listing Rules, specifically Listing Rule 3.1 and 3.1A. There are no financial statements, management discussion, or report data present. The document is a regulatory compliance communication rather than a financial report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2014-02-06 English
Appendix 4C - quarterly 4 pages 30.4KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C Quarterly report for entities admitted on the basis of commitments' and contains detailed financial data including consolidated statement of cash flows, payments to directors, financing facilities, reconciliation of cash, and acquisitions and disposals of business entities. It covers a quarter ended 31 December 2013 and includes substantive financial data and analysis for that period. The document is 6714 characters long, which is sufficient to be a full report rather than a brief announcement. The content aligns with a quarterly financial report rather than an annual report or other filing types. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2014
2014-01-30 English
Director Appointment 1 page 25.1KB
Board/Management Information Classification · 95% confidence The document is a short announcement from Phylogica Ltd regarding the appointment of Dr Bernard Hockings as a director. It includes background information about the company and the new director's shareholding but does not contain financial data, report details, or regulatory filings. The primary content is about a change in the company's board of directors. The document length is 2954 characters, which is short and typical for a management or board change announcement. Therefore, the appropriate classification is Board/Management Information (MANG).
2014-01-23 English
Initial Director's Interest Notice 2 pages 70.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares and options, and the date of appointment. This is a report of personal share transactions or holdings by a company director. The document length is 2384 characters, which is consistent with a director's dealing notice rather than a full financial report or other filings. Therefore, this document fits the definition of 'Director's Dealing' (DIRS).
2014-01-23 English
Change of Director's Interest Notice Hopkins 3 pages 78.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including direct and indirect interests, dates of changes, and nature of transactions. This type of document is a formal notification of personal share transactions by company directors. It does not contain financial statements or company performance data, nor is it an announcement of a report or a regulatory filing unrelated to director dealings. Therefore, it fits the definition of 'Director's Dealing' filings.
2014-01-08 English
Change of Director's Interest Notice McHarrie 2 pages 117.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the date of change. This is a report of personal share transactions by a company director. The document length is 3406 characters, which is consistent with a detailed director's dealing notice. There is no indication that this is an annual report, earnings release, or any other type of report. Therefore, the document fits the definition of Director's Dealing (DIRS).
2014-01-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.